PHARMACIST-LED medication reviews have a positive impact on drug-related readmissions and all-cause ED visits, according to a systematic review and meta-analysis involving 19 randomised controlled trials with 4,805 patients.
CLICK HERE to access the the British Journal of Clinical Pharmacology paper.
PEOPLE with obesity who take glucagon-like peptide-1 receptor agonists (GLP-1RAs) have a reduced risk of cancer compared to those not using those medications, according to US research published today in JAMA Oncology.
PHARMACISTS from across Australia recently came together for the Pharmacy Snow Business Conference at Mt Buller, sharing a passion for skiing alongside their commitment to professional development.
PHARMX Technologies yesterday announced strong results for the financial year ending 30 Jun 2025, with total revenues of $7.5 million, up 13% on the previous corresponding period.
Notifications
